1. Saag MS, Gandhi RT, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults. JAMA. 2020;324(16):1651–69.
2. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. 2021. http://aidsinfo.nih.gov/. Accessed 27 May 2021.
3. Scarsi KK, Havens JP, Podany AT, et al. HIV-1 integrase inhibitors: a comparative review of efficacy and safety. Drugs. 2020;80(16):1649–76.
4. Viiv Healthcare. CABENUVA (cabotegravir and rilpivirine injectable suspension): US prescribing information. 2021. https://gskpro.com/. Accessed 27 May 2021.
5. ViiV Healthcare. Tivicay® (dolutegravir tablets or suspension): US prescribing information. 2021. https://gskpro.com/. Accessed 27 May 2021.